Fluvoxamine for outpatients with COVID-19: where do we stand?

被引：2
|
作者：
Berwanger, Otavio [1 ]
机构：
[1] Acad Res Org ARO, Hosp Israelita Albert Einstein, Sao Paulo, SP, Brazil
来源：
LANCET GLOBAL HEALTH | 2022年 / 10卷 / 01期
关键词：
D O I：
10.1016/S2214-109X(21)00501-5
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：E2 / E3
页数：2
相关论文
共 50 条
  • [21] Directly Acting Antivirals for COVID-19: Where Do We Stand?
    Teoh, Siew L.
    Lim, Yi H.
    Lai, Nai M.
    Lee, Shaun W. H.
    FRONTIERS IN MICROBIOLOGY, 2020, 11
  • [22] Fluvoxamine for symptomatic outpatients with COVID-19
    Wu, Peter E.
    Austin, Emily
    Leong, Derek
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2022, 194 (07) : E258 - E258
  • [23] Abstract for Symposium COVID-19 and suicides in India: Where do we stand?
    Vijayakumar, Lakshmi
    Sarkhel, Sujit
    Mehta, Varun S.
    INDIAN JOURNAL OF PSYCHIATRY, 2022, 64
  • [24] Genetic Predisposition and Inflammatory Inhibitors in COVID-19: Where Do We Stand?
    Sagris, Marios
    Theofilis, Panagiotis
    Antonopoulos, Alexios S.
    Oikonomou, Evangelos
    Tsioufis, Kostas
    Tousoulis, Dimitris
    BIOMEDICINES, 2022, 10 (02)
  • [25] Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand?
    Esposito, Renata
    Mirra, Davida
    Sportiello, Liberata
    Spaziano, Giuseppe
    D'Agostino, Bruno
    BIOMEDICINES, 2022, 10 (11)
  • [26] Immunosuppression in kidney transplant recipients with COVID-19 infection - where do we stand and where are we heading?
    Daoud, Ahmed
    Alqassieh, Ahmad
    Alkhader, Duaa
    Posadas Salas, Maria Aurora
    Rao, Vinaya
    Fulop, Tibor
    Soliman, Karim M.
    RENAL FAILURE, 2021, 43 (01) : 273 - 280
  • [27] Controversy with bromhexine in COVID-19; where we stand
    Tolouian, Ramin
    Mulla, Zuber D.
    IMMUNOPATHOLOGIA PERSA, 2021, 7 (02):
  • [28] Learning from SARS and MERS: COVID-19 reinfection where do we stand?
    Al-Tawfiq, Jaffar A.
    Rabaan, Ali A.
    Al-Omari, Awad
    Al Mutair, Abbas
    Al-Qahtani, Manaf
    Tirupathi, Raghavendra
    TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2021, 41
  • [29] Emergency department-based COVID-19 vaccination: Where do we stand?
    Waxman, Michael J.
    Moschella, Phillip
    Duber, Herbert C.
    Martin, Daniel R.
    Benzoni, Thomas
    Rothman, Richard E.
    Schechter-Perkins, Elissa M.
    ACADEMIC EMERGENCY MEDICINE, 2021, 28 (06) : 707 - 709
  • [30] Superadded Coinfections and Antibiotic Resistance in the Context of COVID-19: Where do We stand?
    Kayarat, Bhavana
    Khanna, Puneet
    Sarkar, Soumya
    INDIAN JOURNAL OF CRITICAL CARE MEDICINE, 2021, 25 (06) : 698 - 702
12345